{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:50:23Z","timestamp":1792482623340,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20224Y0121"],"award-info":[{"award-number":["20224Y0121"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204544"],"award-info":[{"award-number":["82204544"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijantimicag.2026.107793","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:27:43Z","timestamp":1774513663000},"page":"107793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Distribution of piperacillin-tazobactam into cerebrospinal, peritoneal, and pleural fluid in children aged 0\u201318 years"],"prefix":"10.1016","volume":"67","author":[{"given":"Jinglei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiera","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Boast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9056-0305","authenticated-orcid":false,"given":"Gena","family":"Gonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Di Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Chiletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-6438","authenticated-orcid":false,"given":"Andrew","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"McWhinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4929-0929","authenticated-orcid":false,"given":"Jacobus","family":"Ungerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3295-619X","authenticated-orcid":false,"given":"Xiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Gwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107793_bib0001","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/00003495-199957050-00017","article-title":"Piperacillin\/tazobactam: an updated review of its use in the treatment of bacterial infections","volume":"57","author":"Perry","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0004","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.7314\/APJCP.2014.15.11.4549","article-title":"Meropenem versus piperacillin-tazobactam as empiric therapy for febrile neutropenia in pediatric oncology patients","volume":"15","author":"Sezgin","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0005","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12185-020-03031-4","article-title":"Meropenem versus piperacillin\/tazobactam for febrile neutropenia in pediatric patients: efficacy of piperacillin\/tazobactam as a 1-h drip infusion four times a day","volume":"113","author":"Kobayashi","year":"2021","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0006","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/jac\/dkx093","article-title":"Dose optimization of piperacillin\/tazobactam in critically ill children","volume":"72","author":"De Cock","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0007","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/AAC.02089-15","article-title":"Population pharmacokinetics and pharmacodynamics of extended-infusion piperacillin and tazobactam in critically ill children","volume":"60","author":"Nichols","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0008","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/INF.0b013e3182a743c7","article-title":"Population pharmacokinetics of piperacillin\/tazobactam in critically ill young children","volume":"33","author":"Cies","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01227-24","article-title":"Model-informed dose optimization for prophylactic piperacillin-tazobactam in perioperative pediatric critically ill patients","volume":"69","author":"Tan","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0010","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s40262-015-0277-z","article-title":"Prediction of fat-free mass in children","volume":"54","author":"Al-Sallami","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0011","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40262-018-0682-1","article-title":"Piperacillin population pharmacokinetics and dosing regimen optimization in critically ill children with normal and augmented renal clearance","volume":"58","author":"B\u00e9ranger","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0012","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/psp4.12161","article-title":"Model evaluation of continuous data pharmacometric models: metrics and graphics","volume":"6","author":"Nguyen","year":"2017","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0013","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/thorax-2023-220402","article-title":"Antibiotic pharmacokinetics in infected pleural effusions","volume":"79","author":"Arnold","year":"2024","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0014","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/adc.58.12.1006","article-title":"Piperacillin in early neonatal infection","volume":"58","author":"Placzek","year":"1983","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0015","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0022-3476(83)80030-4","article-title":"Pharmacokinetics of intravenously administered piperacillin in preadolescent children","volume":"102","author":"Thirumoorthi","year":"1983","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0016","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","article-title":"Simplified calculation of body-surface area","volume":"317","author":"Mosteller","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0017","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0018","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0022-3476(84)80479-5","article-title":"A simple estimate of glomerular filtration rate in full-term infants during the first year of life","volume":"104","author":"Schwartz","year":"1984","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0019","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0022-3476(85)80697-1","article-title":"A simple estimate of glomerular filtration rate in adolescent boys","volume":"106","author":"Schwartz","year":"1985","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0020","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/bcp.13160","article-title":"Scaling clearance in paediatric pharmacokinetics: all models are wrong, which are useful?","volume":"83","author":"Germovsek","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0021","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/clinids\/22.1.107","article-title":"Piperacillin\/tazobactam: a critical review of the evolving clinical literature","volume":"22","author":"Sanders","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0022","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-NCorrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"Bergstrand","year":"2011","journal-title":"AAPS J"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0023","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10928-017-9542-0","article-title":"An automated sampling importance resampling procedure for estimating parameter uncertainty","volume":"44","author":"Dosne","year":"2017","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0024","doi-asserted-by":"crossref","first-page":"e00601","DOI":"10.1128\/aac.00601-24","article-title":"Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patients","volume":"69","author":"Kumta","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jac\/48.2.259","article-title":"Pharmacokinetic and pharmacodynamic profile of high dose extended interval piperacillin\u2013tazobactam","volume":"48","author":"Kim","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.ijantimicag.2026.107793_bib0026","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3390\/pharmaceutics13091380","article-title":"Similar piperacillin\/tazobactam target attainment in obese versus nonobese patients despite differences in interstitial tissue fluid pharmacokinetics","volume":"13","author":"Busse","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0027","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0028","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. 2020. Breakpoint tables for interpretation of MICs and zone diameters, version 10.0. https:\/\/www.eucast.org\/. Accessed 12 March 2025."},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0029","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/AAC.02747-15","article-title":"Pharmacokinetics-pharmacodynamics of tazobactam in combination with piperacillin in an In vitro infection model","volume":"60","author":"Nicasio","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0030","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1093\/jac\/dkaa363","article-title":"\u03b2-lactam antimicrobial pharmacokinetics and target attainment in critically ill patients aged 1\u2009day to 90\u2009years: the ABDose study","volume":"75","author":"Lonsdale","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.ijantimicag.2026.107793_bib0031","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01260-19","article-title":"Population pharmacokinetics and safety of piperacillin-tazobactam extended infusions in infants and children","volume":"63","author":"Thibault","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0032","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0033","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/515003","article-title":"Antibiotic pharmacodynamics in cerebrospinal fluid","volume":"27","author":"Lutsar","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0034","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00467-008-0997-5","article-title":"Human renal function maturation: a quantitative description using weight and postmenstrual age","volume":"24","author":"Rhodin","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijantimicag.2017.03.025","article-title":"Pharmacokinetics of piperacillin-tazobactam in plasma, peritoneal fluid and peritoneum of surgery patients, and dosing considerations based on site-specific pharmacodynamic target attainment","volume":"50","author":"Murao","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0036","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s12028-020-00947-x","article-title":"Brain exposure to piperacillin in acute hemorrhagic stroke patients assessed by cerebral microdialysis and population pharmacokinetics","volume":"33","author":"Ullah","year":"2020","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0037","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40272-013-0017-5","article-title":"Pharmacokinetics of antibacterial agents in the CSF of children and adolescents","volume":"15","author":"Sullins","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0038","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 Infectious Diseases Society of America\u2019s Clinical Practice Guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0039","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00241-23","article-title":"Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in patients with external ventricular drain","volume":"67","author":"Chen","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107793_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00741-22","article-title":"Population pharmacokinetic modeling and probability of target attainment of ceftaroline in brain and soft tissues","volume":"66","author":"Helfer","year":"2022","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T19:04:43Z","timestamp":1779735883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926000828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0924857926000828"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107793","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distribution of piperacillin-tazobactam into cerebrospinal, peritoneal, and pleural fluid in children aged 0\u201318 years","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107793"}}